Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics Operating Expenses 2010-2024 | NKTR

Nektar Therapeutics operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  
Nektar Therapeutics Annual Operating Expenses
(Millions of US $)
2023 $354
2022 $468
2021 $548
2020 $578
2019 $555
2018 $505
2017 $367
2016 $278
2015 $260
2014 $217
2013 $269
2012 $222
2011 $195
2010 $187
2009 $167
Nektar Therapeutics Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $58
2024-06-30 $73
2024-03-31 $57
2023-12-31 $57
2023-09-30 $69
2023-06-30 $71
2023-03-31 $156
2022-12-31 $74
2022-09-30 $78
2022-06-30 $174
2022-03-31 $141
2021-12-31 $138
2021-09-30 $139
2021-06-30 $139
2021-03-31 $133
2020-12-31 $134
2020-09-30 $133
2020-06-30 $127
2020-03-31 $184
2019-12-31 $144
2019-09-30 $128
2019-06-30 $134
2019-03-31 $149
2018-12-31 $140
2018-09-30 $126
2018-06-30 $114
2018-03-31 $125
2017-12-31 $120
2017-09-30 $83
2017-06-30 $85
2017-03-31 $79
2016-12-31 $70
2016-09-30 $69
2016-06-30 $71
2016-03-31 $68
2015-12-31 $69
2015-09-30 $60
2015-06-30 $66
2015-03-31 $66
2014-12-31 $57
2014-09-30 $53
2014-06-30 $51
2014-03-31 $56
2013-12-31 $67
2013-09-30 $67
2013-06-30 $66
2013-03-31 $68
2012-12-31 $65
2012-09-30 $51
2012-06-30 $51
2012-03-31 $56
2011-12-31 $50
2011-09-30 $48
2011-06-30 $52
2011-03-31 $45
2010-12-31 $66
2010-09-30 $44
2010-06-30 $41
2010-03-31 $37
2009-12-31 $45
2009-09-30 $39
2009-06-30 $43
2009-03-31 $40
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.190B $0.090B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.207B 30.48
Takeda Pharmaceutical (TAK) Japan $43.337B 9.02
Sandoz Group AG (SDZNY) Switzerland $19.481B 0.00
Merck (MKKGY) Germany $19.205B 17.20
Astellas Pharma (ALPMY) Japan $18.223B 16.78
United Therapeutics (UTHR) United States $16.104B 15.84
Summit Therapeutics (SMMT) United States $14.749B 0.00
Neurocrine Biosciences (NBIX) United States $12.062B 31.94
Shionogi (SGIOY) Japan $11.921B 11.42
Catalent (CTLT) United States $10.687B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.062B 6.91
Madrigal Pharmaceuticals (MDGL) United States $6.852B 0.00
Orion OYJ (ORINY) Finland $6.653B 18.71
Corcept Therapeutics (CORT) United States $5.690B 43.10
Ionis Pharmaceuticals (IONS) United States $5.329B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.116B 0.00
PTC Therapeutics (PTCT) United States $3.036B 0.00
Dyne Therapeutics (DYN) United States $3.020B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.613B 15.63
Catalyst Pharmaceuticals (CPRX) United States $2.551B 11.56
Arrowhead Pharmaceuticals (ARWR) United States $2.312B 0.00
Soleno Therapeutics (SLNO) United States $2.233B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.188B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.907B 0.00
Evotec AG (EVO) Germany $1.825B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.797B 0.00
Xencor (XNCR) United States $1.654B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.493B 0.00
Indivior (INDV) United States $1.442B 5.87
Harrow (HROW) United States $1.414B 0.00
Ocular Therapeutix (OCUL) United States $1.402B 0.00
Cassava Sciences (SAVA) United States $1.347B 0.00
ARS Pharmaceuticals (SPRY) United States $1.340B 0.00
Guardian Pharmacy Services (GRDN) United States $1.339B 0.00
Enliven Therapeutics (ELVN) United States $1.279B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.164B 0.00
Ardelyx (ARDX) United States $1.135B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.032B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.24
Bioventus (BVS) United States $0.941B 29.72
Relay Therapeutics (RLAY) United States $0.803B 0.00
Cronos Group (CRON) Canada $0.776B 0.00
USANA Health Sciences (USNA) United States $0.744B 13.80
Elite Pharmaceuticals (ELTP) United States $0.721B 0.00
Exscientia (EXAI) United Kingdom $0.633B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.610B 0.00
Tourmaline Bio (TRML) United States $0.603B 0.00
Organogenesis (ORGO) United States $0.541B 0.00
Altimmune (ALT) United States $0.531B 0.00
ProKidney (PROK) United States $0.521B 0.00
Savara (SVRA) United States $0.505B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.488B 0.00
Zevra Therapeutics (ZVRA) United States $0.479B 0.00
Esperion Therapeutics (ESPR) United States $0.475B 0.00
OmniAb (OABI) United States $0.454B 0.00
Xeris Biopharma Holdings (XERS) United States $0.449B 0.00
Siga Technologies (SIGA) United States $0.447B 5.22
Aquestive Therapeutics (AQST) United States $0.439B 0.00
Korro Bio (KRRO) United States $0.437B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.421B 170.79
Verve Therapeutics (VERV) United States $0.410B 0.00
Larimar Therapeutics (LRMR) United States $0.407B 0.00
4D Molecular Therapeutics (FDMT) United States $0.401B 0.00
Akebia Therapeutics (AKBA) United States $0.397B 0.00
KalVista Pharmaceuticals (KALV) United States $0.391B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.358B 0.00
Avita Medical (RCEL) United States $0.340B 0.00
Aclaris Therapeutics (ACRS) United States $0.328B 0.00
Lyell Immunopharma (LYEL) United States $0.310B 0.00
Sage Therapeutics (SAGE) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.295B 17.55
Aldeyra Therapeutics (ALDX) United States $0.294B 0.00
Pyxis Oncology (PYXS) United States $0.247B 0.00
Silence Therapeutics (SLN) United Kingdom $0.209B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.202B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.200B 0.00
Lexeo Therapeutics (LXEO) United States $0.199B 0.00
Acrivon Therapeutics (ACRV) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.193B 0.00
Heron Therapeutics (HRTX) United States $0.181B 0.00
Nanobiotix S.A (NBTX) France $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.173B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Achieve Life Sciences (ACHV) Canada $0.149B 0.00
CytoDyn (CYDY) United States $0.146B 0.00
Incannex Healthcare (IXHL) Australia $0.136B 0.00
Cardiol Therapeutics (CRDL) Canada $0.135B 0.00
Telomir Pharmaceuticals (TELO) United States $0.131B 0.00
Context Therapeutics (CNTX) United States $0.124B 0.00
Avalo Therapeutics (AVTX) United States $0.115B 0.00
Journey Medical (DERM) United States $0.111B 0.00
VAXART, INC (VXRT) United States $0.110B 0.00
Century Therapeutics (IPSC) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.105B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.093B 24.37
Regulus Therapeutics (RGLS) United States $0.093B 0.00
Arch Biopartners (ACHFF) Canada $0.093B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
CASI Pharmaceuticals (CASI) China $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Vivani Medical (VANI) United States $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
Inotiv (NOTV) United States $0.073B 0.00
Scienture Holdings (SCNX) United States $0.069B 0.00
ElectroCore (ECOR) United States $0.066B 0.00
AlloVir (ALVR) United States $0.065B 0.00
Metagenomi (MGX) United States $0.063B 0.00
Champions Oncology (CSBR) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Nutriband (NTRB) United States $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
OptiNose (OPTN) United States $0.051B 0.00
Unicycive Therapeutics (UNCY) United States $0.050B 0.00
Protara Therapeutics (TARA) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
SCYNEXIS (SCYX) United States $0.045B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
CERo Therapeutics Holdings (CERO) United States $0.039B 0.00
Carisma Therapeutics (CARM) United States $0.036B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Citius Pharmaceuticals (CTXR) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
BioVie (BIVI) United States $0.033B 0.00
DURECT (DRRX) United States $0.030B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
Oruka Therapeutics (ORKA) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
GlycoMimetics (GLYC) United States $0.024B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.022B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Tempest Therapeutics (TPST) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.009B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.02
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.59